# TEDDM1

## Overview
TEDDM1 is a gene that encodes the transmembrane epididymal protein 1, which is categorized as a transmembrane protein. This protein is primarily expressed in the epididymis and is thought to play a role in immune processes and the protection of sperm against pathogens. The gene's expression and function have been linked to various physiological and pathological conditions, including psychiatric disorders, cancer, and male reproductive health. Alterations in TEDDM1 expression have been associated with psychiatric disorders such as bipolar disorder, particularly in the context of COVID-19, as well as with prostate cancer progression and metastasis. Additionally, its dysregulation in the reproductive system, particularly in the testes of PLAG1 knockout mice, suggests a potential impact on male fertility (Pang2019Competing; Juma2017PLAG1; Xia2022Immune).

## Clinical Significance
The TEDDM1 gene has been implicated in several conditions due to its altered expression or interactions. In the context of psychiatric disorders and COVID-19, TEDDM1 is identified as an overexpressed gene in the differential expression and transcription factor network analysis, suggesting its potential role in the interaction between COVID-19 and psychiatric disorders such as bipolar disorder (BD) (Xia2022Immune). 

In prostate cancer, TEDDM1 is listed as a significant signature in the coexpression network analysis related to lymphatic metastasis, indicating its potential involvement in cancer progression and metastasis (Pang2019Competing). 

In the reproductive system, TEDDM1 is notably upregulated in the testes of PLAG1 knockout mice, where it is typically expressed in the epididymis. This aberrant expression suggests a role in immune processes and sperm protection against pathogens, potentially linking TEDDM1 to male infertility when its expression is dysregulated (Juma2017PLAG1). 

These findings highlight the importance of TEDDM1 in various pathological contexts, although its specific clinical significance and the mechanisms by which it contributes to these conditions require further investigation.


## References


[1. (Pang2019Competing) Xiaocong Pang, Ying Zhao, Jinhua Wang, Wan Li, Qian Xiang, Zhuo Zhang, Shiliang Wu, Ailin Liu, Guanhua Du, and Yimin Cui. Competing endogenous rna and coexpression network analysis for identification of potential biomarkers and therapeutics in association with metastasis risk and progression of prostate cancer. Oxidative Medicine and Cellular Longevity, 2019:1–21, August 2019. URL: http://dx.doi.org/10.1155/2019/8265958, doi:10.1155/2019/8265958. This article has 10 citations and is from a poor quality or predatory journal.](https://doi.org/10.1155/2019/8265958)

[2. (Juma2017PLAG1) Almas R. Juma, Sylvia V. H. Grommen, Moira K. O’Bryan, Anne E. O’Connor, D. Jo Merriner, Nathan E. Hall, Stephen R. Doyle, Pauliina E. Damdimopoulou, Daniel Barriga, Adam H. Hart, Wim J. M. Van de Ven, and Bert De Groef. Plag1 deficiency impairs spermatogenesis and sperm motility in mice. Scientific Reports, July 2017. URL: http://dx.doi.org/10.1038/s41598-017-05676-4, doi:10.1038/s41598-017-05676-4. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-05676-4)

[3. (Xia2022Immune) Jing Xia, Shuhan Chen, Yaping Li, Hua Li, Minghong Gan, Jiashuo Wu, Clare Colette Prohaska, Yang Bai, Lu Gao, Li Gu, and Dongfang Zhang. Immune response is key to genetic mechanisms of sars-cov-2 infection with psychiatric disorders based on differential gene expression pattern analysis. Frontiers in Immunology, February 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.798538, doi:10.3389/fimmu.2022.798538. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.798538)